Topic: Drug Pricing

JD Supra Corporate Brief: Drug Pricing in China, Corruption in Brazil, Climate Change in Congress, Antitrust Law in Europe

A Friday in July and you’re reading the JD Supra Corporate Brief? Does it get any better? China is questioning 60 pharmaceutical companies about their drug pricing (Dechert) Myriad is going on the litigation offensive to protect its BRCA1 and BRCA2 patents (MBHB) Even the ITC is targeting patent trolls… (Duane Morris) Companies operating in… Read more »